维普中文期刊产品整合服务
978篇 您的检索式:作者名="BARTONE C"
    题名 作者 年代 出处 被引量
1甘肃大地湾遗址距今6万年来的考古记录与旱作农业起源显示文摘报道了中国北方早期旱作农业起源地之一的甘肃秦安大地湾遗址Dadiwan06探方的最新发掘成果,根据黄土-古土壤序列、绝对测年(AMS 14C和光释光测年)、气候事件年龄和考古分析,为Dadiwan06探方的地层沉积建立了6.5万年的年代框架.考古材料分析显示,Dadiwan06探方完整记录了石英打制技术制品、细石器技术制品、大地湾一期文化以及仰韶文化陶器制品等分别代表中国北方原始采集狩猎经济、先进采集狩猎经济、早期栽培经济与成熟农业经济的4个不同发展阶段,反映了大地湾遗址距今6.0万年以来由采集狩猎经济逐步向农业经济过渡的持续人类活动历史。张东菊 陈发度 BETTINGER R L BARTON L 吉笃学 MORGAN C 王辉 程晓钟 董广辉 GUILDERSON T P 赵晖 2010科学通报2010,55,10:42
2Archaeological records of Dadiwan in the past 60 ka and the origin of millet agriculture显示文摘This paper reports the recent excavation of Unit Dadiwan06 at the Dadiwan site in Qin’an County, Gansu.A 65 ka chronological framework is established for Dadiwan06 on the basis of absolute dating (AMS 14C and OSL), stratigraphy, climate change events and archaeology.Artifact distributions reveal patterns of human behavioral variation and adaptation over the past 60 ka, from primitive hunting and gathering to advanced hunting and gathering, to primitive Neolithic agriculture, and finally to advanced Neolithic agriculture.ZHANG DongJu CHEN FaHu BETTINGER R L BARTON L JI DuXue MORGAN C WANG Hui CHENG XiaoZhong DONG GuangHui GUILDERSON T P ZHAO Hui 2010Chinese Science Bulletin2010,55,16:6
3Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma显示文摘Glioblastoma multiforme(GBM) is the most common malignant primary brain tumor with a survival prognosis of 14-16 mo for the highest functioning patients. Despite aggressive, multimodal upfront therapies, the majority of GBMs will recur in approximately six months. Salvage therapy options for recurrent GBM(r GBM) are an area of intense research. This study compares recent survival and quality of life outcomes following Gamma Knife radiosurgery(GKRS) salvage therapy. Following a Pub Med search for studies usingGKRS as salvage therapy for malignant gliomas, nine articles from 2005 to July 2013 were identified which evaluated rG BM treatment. In this review, we compare overall survival following diagnosis, overall survival following salvage treatment, progression-free survival, time to recurrence, local tumor control, and adverse radiation effects. This report discusses results for rG BM patient populations alone, not for mixed populations with other tumor histology grades. All nine studies reported median overall survival rates(from diagnosis, range:16.7-33.2 mo; from salvage, range:9-17.9 mo). Three studies identified median progression-free survival(range:4.6-14.9 mo). Two showed median time to recurrence of GBM. Two discussed local tumor control. Six studies reported adverse radiation effects(range:0%-46% of patients). The greatest survival advantages were seen in patients who received GKRS salvage along with other treatments, like resection or bevacizumab, suggesting that appropriately tailored multimodal therapy should be considered with each rG BM patient. However, there needs to be a randomized clinical trial to test GKRS for rG BM before the possibility of selection bias can be dismissed.Erik W Larson Halloran E Peterson Wayne T Lamoreaux Alexander R MacKay Robert K Fairbanks Jason A Call Jonathan D Carlson Benjamin C Ling John J Demakas Barton S Cooke Christopher M Lee 2014World Journal of Clinical Oncology2014,5,2:5
4Fundamentals of rock joint deformation显示文摘Bandis S C Lumsden A C Barton N R 1983International Journal of Rock Mechanics and Mining Sciences & GeomechanicsAbstracts1983,20,6:2
5Fundamentals of rock joint deformation显示文摘BANDIS S C LUMSDEN A C BARTON N R 1983International Journal of Rock Mechanics and Mining Science and Geomechartics Abstracts1983,20,6:1
6A predictive tool to evaluate disc brake squeal propensity, Part 2: System linearization and modal analysis显示文摘LEE Y S BROOKS P C BARTON D C 2003International Journal of Vehicle Design2003,31,:1
7Comparative wear under four different tribological conditions of acetylene enhanced cross-linked ultra high molecularweight polyethylene显示文摘Marrs H Barton D C Jones R A 1999J Mater Sci:Mater Med1999,10,:1
8Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine显示文摘O'NEIL M M KENNEDY C A BARTON R W 2001Gene Therapy2001,,8:1
9High - dose epinephrine improve the return of spontaneous circulation rates in human victims of cardiac arrest 显示文摘BARTON C 1991Ann Emerg Med1991,20,:1
10Opioid receptor subtype control of galinin-induced feeding显示文摘 York DA Bray GA 1996Peptides1996,17,2:1
11Characterizing perflu- orooctanoate in ambient air near the fence line of a manufacturing facility : Comparing modeled and monitored values 显示文摘Barton C Butler L E Zarzecki C J 2006Journal of Air Waste Managenvent Association2006,56,1:1
12Ranging airport pseudolite for local area augmentation 显示文摘Bartone C van Graas F 2000IEEE Transactions on Aerospace and Electronic Systems2000,36,1:1
13Identification and molecular characterization of shrunken-2 cDNA clones of maize 显示文摘Bhave M R Lawrence S Barton C 1990Plant Cell1990,2,:1
14MicroRNA control of PHABULOSA in leaf development:importance of pairing to the mieroRNA 5' region 显示文摘Mallory A C Reinhart B J Jones-Rhoades M W Tang G L Zamore P D Barton M K Barrel D P 2004The EMBO Journal2004,23,:1
15Psychological correlates of PTSD symptoms following stroke显示文摘Merriman C Norman P Barton J 2007Psychol Health Med2007,12,5:1
16A digitally controlled oscillator in a 90 nm digital CMOS process for mobile phones显示文摘Staszewski R B Hung C M Barton N 2005IEEE J Solid State Circuits2005,40,11:1
17On demonstrating DNA intercalation显示文摘Long E C Barton J K 1990Accounts of Chemical Research1990,23,9:1
18Representing Student Achievement in Sciencet显示文摘Fusco D Barton A C 2001Journal of Research in Science Teaching2001,38,3:1
19On demonstration DNA intercalation显示文摘Long E C Barton J K 1990Accounts Chem Res1990,23,9:1
20A methanol sensor for portable direct methanol fuel cells显示文摘Barton S A C Murach B L Fuller T F 1998Journal of the electrochemical society1998,145,11:1
返回顶部 每页显示:
共49页 首页 上一页 第1页 下一页 末页 /49 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费